Orbita, Inc. has unveiled major upgrade enhancements to its Orbita Voice platform that enables healthcare organizations and service providers to create and maintain powerful apps for voice-assistants and conversational AI platforms like Amazon Alexa and Google Assistant. Orbita Voice is the first healthcare-centric solution designed to easily create and manage intelligent, conversational skills for voice-powered assistants such as Amazon Echo and Google Home. Clinical trial investigators and coordinators use Orbita Voice’s intuitive tools to create interactive voice surveys and collect voice responses, and use built-in analytics to track user engagement and respond to user input.
This latest version of Orbita Voice adds important new features to accelerate development and streamline maintenance of voice-first, enterprise healthcare applications, including:
– Omni-Channel Publishing: Create once and publish to multiple voice assistants, chat bots, and other conversational AI interfaces for smart speakers, mobile apps, SMS, and interactive voice response (IVR) phone applications
– Integrated Project Management: Manage multiple voice projects with concurrent editing, version control, and much more
– Content and Experience Management: Empower non-technical staff with pre-built templates optimized for healthcare applications (assessment surveys, FAQs, calendar management, messaging, and more)
– Flexible Integration: Readily add voice experiences to existing business systems, processes, and digital channels using flexible APIs and 3rd party integrations.
“Orbita’s technology offers proven functionality, scalability and stable integration, which enables ERT to develop new solutions that help patients to stay engaged in clinical trials and remain compliant with their treatment,” said Karin Beckstrom, senior product manager at ERT, a leading clinical trial services company collaborating with Orbita to research innovative approaches for data procurement and management in a statement. “We look forward to applying this capability in our solutions so that researchers are able to minimize risks and accelerate their clinical development programs.”
